Sharda Cropchem (SHARDACROP) Q2 26/27 earnings summary

Executive summary

• Q2 FY27 consolidated revenue was ₹105,168.19 lakh, up 13% YoY; EBITDA rose 18% and net profit increased 23%.

• H1 revenue rose 11% to ₹212,545.00 lakh, while net profit declined to ₹17,974.38 lakh from ₹21,715.36 lakh, reflecting higher prior-year forex gains.

• IP-led, asset-light platform served 80+ countries through 525+ distributors; portfolio had 3,044 registrations and 946 applications in the pipeline at 30 September 2026.

Financial highlights

• Q2 gross profit was ₹377.9 crore, up 18%; EBITDA was ₹164.5 crore, up 18%, and PAT was ₹91.7 crore, up 23% YoY.

• H1 gross profit rose 15% to ₹771.9 crore and EBITDA rose 22% to ₹342.9 crore; reported PAT fell 17% YoY.

• H1 PBT was ₹225.9 crore versus ₹255 crore; excluding forex, PBT rose 16% to ₹219 crore. H1 included a ₹7.2 crore forex loss versus ₹67 crore gain in H1 FY26.

• Q2 PBT excluding forex gains was ₹108 crore, up 17% YoY.

Outlook and guidance

• FY27 revenue growth guidance remains 10%-15%, with EBITDA margin guidance of 18%-20%; improvement is expected in H2 from product mix and operating leverage.

• H2 gross margins are expected to hold or improve versus H1; NAFTA margins were described as sustainable and European performance is expected to improve as conditions normalize.

• Priorities include customer engagement, distribution, selective geographic expansion, dossier development, productivity, cost optimization and disciplined working-capital management.